Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

Please add ResearchGrants@BrightFocus.org to your institution’s white list to insure that the notification is not blocked by your organization’s SPAM filters.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

 
 
BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

 

Macular Degeneration Research
Current Award

Dr. Jiyang Cai

Jiyang Cai, Ph.D.

University of Texas Medical Branch
Galveston, TX, United States

Title: Exosomal microRNA from the RPE
Non-Technical Title: Small RNAs as signaling molecules between the RPE and choroid

Duration: July 1, 2012 - June 30, 2015
Award Type: Standard
Award Amount: $100,000

Summary:

Interactions between the retinal pigment epithelium (RPE,) the cell layer that nourishes and detoxifies the retina, and their underlying choroidal blood vessels are critical in maintaining the structure and functions of the outer retina. Dr. Jiyang Cai and colleagues are examining how RPE cell delivery bubbles (called microvesicles) can transfer genetic materials to the choroidal blood vessel cells and alter their functions. Results from this study could reveal a new cause of age-related macular degeneration (AMD).

Details:

Dr. Jiyang Cai and colleagues will use integrated genetics tools to study animals engineered to have age-related macular degeneration (AMD). Specifically for this project, they are investigating the hypothesis that the RPE and blood vessel cells communicate with each other by transferring small genetic fragments (called microRNAs) that then change the functions of the recipient cells.

Recent studies suggest that not only are there problems with the RPE, but that the choroidal blood vessels underneath the RPE also degenerate early in AMD. The RPE and the choroidal endothelial cells are separated by a thin barrier known as Bruch's membrane. It is unclear what signals are exchanged between the two types of cells and how their normal communication is interrupted during early AMD. Preliminary work completed by this research group has shown that microvesicles released from the RPE contain various small RNA fragments. The proposed studies will further examine how stress conditions related to AMD may change the content of these RPE microvesicles that, in turn, may alter functions of the choroidal endothelial cells.

This proposal will use various innovative approaches, such as a new mouse engineered to have AMD and a technique called high throughput gene array. Cai is studying a mechanism that accounts for the early dysfunction of RPE and choroid—perhaps chronic oxidative injury is a major factor of RPE degeneration and dry AMD. The results from this research could lead to a new AMD treatment with emphasis on strengthening the protection and repair mechanisms of the RPE. Hopefully, this can be achieved by target-based nutritional intervention combined with a healthy lifestyle.

Investigator Biography:

Dr. Jiyang Cai is an Assistant Professor of Ophthalmology at the University of Texas Medical Branch at Galveston. He completed his doctoral studies at Emory University and previously held a faculty position at Vanderbilt University. Cai's laboratory focuses on molecular mechanisms of age-related macular degeneration (AMD) and uses animal model, cell culture, and clinical approaches to study different perspectives of the disease. In addition to the BrightFocus award, Cai has received a number of grants from both NIH and various eye research foundations.